# Acer Therapeutics Inc. (ACER)

Source: https://www.quantisnow.com/company/ACER
Generated: 2026-11-09T10:47:49.235Z

- Ticker: ACER
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: acertx.com

## About

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates: EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was founded in 2013 and is headquartered in Newton, Massachusetts.

## Latest ACER news and filings

- 2024-03-19 13:31 UTC [Market Insight] [Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant](https://www.quantisnow.com/insight/bayers-third-menopausal-relief-drug-trial-meets-primary-goal-german-5353657)
- 2023-11-30 12:30 UTC [SEC Form 15-12G filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-acer-therapeutics-inc-5110185)
- 2023-11-27 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-acer-therapeutics-inc-5103160)
- 2023-11-27 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-acer-therapeutics-inc-5103150)
- 2023-11-20 22:09 UTC [SEC Form 4] [Aselage Steve returned 483,741 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/aselage-steve-returned-483741-shares-to-the-company-closing-all-5096623)
- 2023-11-20 22:07 UTC [SEC Form 4] [Dunn John Michael returned 27,380 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/dunn-john-michael-returned-27380-shares-to-the-company-closing-5096607)
- 2023-11-20 22:05 UTC [SEC Form 4] [Joseph Donald returned 14,285 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/joseph-donald-returned-14285-shares-to-the-company-closing-all-5096585)
- 2023-11-20 22:03 UTC [SEC Form 4] [Schelling Chris returned 2,712,529 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/schelling-chris-returned-2712529-shares-to-the-company-closing-all-5096575)
- 2023-11-20 22:03 UTC [SEC Form 4] [Palmin Harry S returned 125,000 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/palmin-harry-s-returned-125000-shares-to-the-company-closing-5096573)
- 2023-11-20 22:01 UTC [SEC Form 4] [Davis Jefferson E returned 71,645 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/davis-jefferson-e-returned-71645-shares-to-the-company-closing-5096563)
- 2023-11-20 21:51 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-acer-therapeutics-inc-5096498)
- 2023-11-20 21:43 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096450)
- 2023-11-20 21:42 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096446)
- 2023-11-20 21:41 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096439)
- 2023-11-20 21:41 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096436)
- 2023-11-20 21:40 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096428)
- 2023-11-20 21:39 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096422)
- 2023-11-20 21:39 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096418)
- 2023-11-20 21:38 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096411)
- 2023-11-20 21:38 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096406)
- 2023-11-20 21:37 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096405)
- 2023-11-20 21:37 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096394)
- 2023-11-20 21:35 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-acer-therapeutics-inc-5096387)
- 2023-11-20 21:32 UTC [SEC Form POS AM filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-acer-therapeutics-inc-5096359)
- 2023-11-20 21:31 UTC [SEC Form POS AM filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-acer-therapeutics-inc-5096352)
- 2023-11-20 21:26 UTC [SEC Form 8-K] [Acer Therapeutics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/acer-therapeutics-inc-filed-sec-form-8-k-completion-of-acquisition-5096257)
- 2023-11-14 11:04 UTC [SEC Form NT 10-Q filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-acer-therapeutics-inc-5082641)
- 2023-11-08 21:13 UTC [SEC Form 425] [SEC Form 425 filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-acer-therapeutics-inc-5070477)
- 2023-11-08 21:11 UTC [SEC Form 8-K] [Acer Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events](https://www.quantisnow.com/insight/acer-therapeutics-inc-filed-sec-form-8-k-submission-of-matters-5070411)
- 2023-11-02 12:51 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-acer-therapeutics-inc-5053472)
- 2023-11-02 12:50 UTC [SEC Form 425] [SEC Form 425 filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-acer-therapeutics-inc-5053466)
- 2023-11-02 12:49 UTC [SEC Form 8-K] [Acer Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement](https://www.quantisnow.com/insight/acer-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5053457)
- 2023-11-02 12:30 UTC [Conference Announcement] [Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals](https://www.quantisnow.com/insight/leading-independent-proxy-advisory-firms-iss-and-glass-lewis-recommend-5053347)
- 2023-10-30 11:24 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-acer-therapeutics-inc-5042768)
- 2023-10-10 21:17 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Acer Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-acer-therapeutics-inc-5013562)
- 2023-09-06 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-intraday-session-4955971)
- 2023-09-05 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-intraday-session-4952704)
- 2023-09-05 15:00 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-september-5-2023-4952391)
- 2023-09-05 12:45 UTC [Market Chatter] [HC Wainwright & Co. Downgrades Acer Therapeutics to Neutral](https://www.quantisnow.com/insight/hc-wainwright-co-downgrades-acer-therapeutics-to-neutral-4951947)
- 2023-09-04 13:05 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-pre-market-session-4950869)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ACER
- Earnings history: https://www.quantisnow.com/earnings/ACER
- Dividend history: https://www.quantisnow.com/dividends/ACER
- Insider transactions: https://www.quantisnow.com/insiders/ACER
- Options chain: https://www.quantisnow.com/options/ACER
- SEC 8-K filings only: https://www.quantisnow.com/company/ACER/8-k
- RSS and alerts for ACER: https://www.quantisnow.com/docs/rss-feeds.md